Anmelden Kostenlos registrieren

Shenzhen Chipscreen Biosciences Co Kapitalrendite

Was ist das Kapitalrendite von Shenzhen Chipscreen Biosciences Co?

Kapitalrendite von Shenzhen Chipscreen Biosciences Co., Ltd. ist -6.36%

Was ist die Definition von Kapitalrendite?



Die Eigenkapitalrendite ist ein Maß für die Rentabilität eines Unternehmens im Verhältnis zum Buchwert des Eigenkapitals. Sie wird berechnet, indem das Nettoergebnis des Geschäftsjahres durch das gesamte Eigenkapital geteilt wird.

The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.

Kapitalrendite von Unternehmen in Health Care Sektor auf SSE im Vergleich zu Shenzhen Chipscreen Biosciences Co

Was macht Shenzhen Chipscreen Biosciences Co?

Shenzhen Chipscreen Biosciences Co., Ltd. engages in the research, development, and sale of original small molecule drugs. The company develops precursor compounds and original new drug product lines that are in various research phase of the specific global intellectual property protection in three areas, such as cancer, metabolic diseases, and autoimmune diseases. Shenzhen Chipscreen Biosciences Co., Ltd. was founded in 2001 and is based in Shenzhen, China.

Unternehmen mit kapitalrendite ähnlich Shenzhen Chipscreen Biosciences Co